SCHEMBL6831709

SCHEMBL6831709

NCCCC[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25275677 0.97 ALDH1A1 (0.56)
SCHEMBL9321036 0.97 ALDH1A1 (0.56)
SCHEMBL9322072 0.97 ALDH1A1 (0.56)
Hydrochloric Acid SCHEMBL8058609 0.97
SCHEMBL1076685 0.97
SCHEMBL17550102 0.91
SCHEMBL719096 0.84 ALDH1A1 (0.67)
SCHEMBL16341166 0.81 ALDH1A1 (0.72)
SCHEMBL715302 0.81 ALDH1A1 (0.72)
SCHEMBL16341718 0.81 ALDH1A1 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040005676-A1 Biocatalytic reduction of nitro groups DIVERSA CORPORATION 2004-01-08 US claimed
WO-2003062399-A2 BIOCATALYTIC REDUCTION OF NITRO GROUPS DIVERSA CORPORATION (US) 2003-07-31 WO claimed
US-20040005676-A1 Biocatalytic reduction of nitro groups DIVERSA CORPORATION 2004-01-08 US disclosed
WO-2003062399-A2 BIOCATALYTIC REDUCTION OF NITRO GROUPS DIVERSA CORPORATION (US) 2003-07-31 WO disclosed
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed
CN-1079679-C Cascade polymer complexes, method for the production thereof and pharmaceutical agents containing said complexes SCHERING AG (DE) 2002-02-27 CN disclosed
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US disclosed
CN-1189779-A Cascade polymer complexes, method for the production thereof and pharmaceutical agents containing said complexes SCHERING AG (DE) 1998-08-05 CN disclosed
EP-0504064-B1 Novel thrombin inhibitors MERRELL PHARMA INC (US) 1998-05-13 EP disclosed
CN-1151701-A Concatemer-polymer complexes, process for their preparation and pharmaceutical agents containing them SCHERING AG (DE) 1997-06-11 CN disclosed
US-5563156-A ANTICOAGULANTS, ANTIASTHMA AGENTS MERRELL PHARMACEUTICALS INC. (US) 1996-10-08 US disclosed
US-5498779-A ANTICOAGULANTS AND TREATMENT OF ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1996-03-12 US disclosed
US-5391705-A Anticoagulants, treats thrombophlebitis, coronary thrombosis and asthma MERRELL DOW PHARMACEUTICALS INC. (US) 1995-02-21 US disclosed
EP-0387106-B1 Novel diamine compounds, production of the same and polyamideimide resins produced therefrom TOMOEGAWA PAPER CO LTD (JP) 1994-02-02 EP disclosed
EP-0504064-A1 Novel thrombin inhibitors MERRELL PHARMACEUTICALS INC. (US) 1992-09-16 EP disclosed
US-5019642-A Novel diamine compounds, production of the same and polyamideimide resins produced therefrom TOMOEGAWA PAPER CO., LTD. (JP) 1991-05-28 US disclosed
EP-0387106-A1 Novel diamine compounds, production of the same and polyamideimide resins produced therefrom TOMOEGAWA PAPER CO. LTD. (JP) 1990-09-12 EP disclosed